Apellis Pharmaceuticals (APLS)
NASDAQ:APLS
Want to see APLS full AI Analyst Report?
Apellis Pharmaceuticals (APLS) Ownership Overview
3.99% Insiders
18.55% Mutual Funds
1.46% Other Institutional Investors
21.46% ETFs
54.54% Public Companies and
Individual Investors
The ownership structure of Apellis Pharmaceuticals (APLS) stock is a mix of institutional, retail, and individual investors. Approximately 41.47% of the company’s stock is owned by Institutional Investors, 3.99% is owned by Insiders, and 54.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 13, 2026 | xxxxxxxxxxxxx | $8151 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $73353 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $44913 | |
Jan 23, 2026 | xxxxxxxxxxxxx | $128993 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $3612382 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $233666 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,269,161 | Institution | 8.02% | 420,727,526 | |
| 9,414,982 | Institution | 7.35% | 385,731,813 | |
| 8,305,688 | Institution | 6.49% | 340,284,037 | |
| 7,632,548 | Institution | 5.96% | 312,705,492 | |
| 5,251,928 | Institution | 4.10% | 215,171,490 | |
| 1,805,259 | Insider | 1.41% | 73,961,461 | |
| 1,749,370 | Institution | 1.37% | 71,671,689 | |
| 1,177,222 | Insider | 0.92% | 48,230,785 | |
| 1,040,602 | Institution | 0.81% | 42,633,464 | |
| 796,939 | Insider | 0.62% | 32,650,591 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,305,688 | Institution | 6.49% | 340,284,037 | |
| 7,632,548 | Institution | 5.96% | 312,705,492 | |
| 1,749,370 | Institution | 1.37% | 71,671,689 | |
| 1,040,602 | Institution | 0.81% | 42,633,464 | |
| 704,768 | Institution | 0.55% | 28,874,345 | |
| 594,859 | Institution | 0.46% | 24,371,373 | |
| 524,737 | Institution | 0.41% | 21,498,475 | |
| 524,100 | Institution | 0.41% | 21,472,377 | |
| 467,487 | Institution | 0.37% | 19,152,942 | |
| 418,800 | Institution | 0.33% | 17,158,236 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,245,728 | Institution | 4.88% | 255,887,476 | |
| 3,691,846 | Institution | 2.88% | 151,254,931 | |
| 3,424,564 | Institution | 2.67% | 137,770,210 | |
| 2,511,276 | Institution | 1.96% | 101,028,633 | |
| 1,407,063 | Institution | 1.10% | 56,606,144 | |
| 1,146,436 | Institution | 0.90% | 46,121,120 | |
| 938,695 | Institution | 0.73% | 38,458,334 | |
| 901,384 | Institution | 0.70% | 36,929,702 | |
| 712,488 | Institution | 0.56% | 29,190,633 | |
| 652,904 | Institution | 0.51% | 26,749,477 |
FAQ
Who Owns Apellis Pharmaceuticals (APLS)?
According to the latest TipRanks data, approximately 1.46% of the company's stock is held by institutional investors, 3.99% is held by insiders, and 54.54% is held by retail investors.
What percentage of Apellis Pharmaceuticals (APLS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.46% of Apellis Pharmaceuticals (APLS) stock is held by institutional investors.
What percentage of Apellis Pharmaceuticals (APLS) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.54% of Apellis Pharmaceuticals (APLS) stock is held by retail investors.
Who owns the most shares of Apellis Pharmaceuticals (APLS)?
iShares owns the most shares of Apellis Pharmaceuticals (APLS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.